Inhibition of microRNA-660-5p decreases breast cancer progression through direct targeting of TMEM41B
Our study highlights the upregulation and involvement of miR-660-5p in breast cancer cell proliferation, migration, invasion, and angiogenesis. Additionally, we identified TMEM41B as a direct target of miR-660-5p in breast cancer cells.
Authors
- José Roberto Estupiñan‐Jiménez (ORCID: https://orcid.org/0000-0002-8252-4873)
- Claudia Altamirano‐Torres (ORCID: https://orcid.org/0000-0001-5919-0660)
- Vianey González-Villasana (ORCID: https://orcid.org/0000-0002-9896-2210)
- Pablo E. Vivas‐Mejía (ORCID: https://orcid.org/0000-0002-2001-857X)
- Mohammed H. Rashed (ORCID: https://orcid.org/0000-0002-5911-530X)
- Gabriel Lopez‐Berestein
- Diana Reséndez‐Pérez (ORCID: https://orcid.org/0000-0002-4709-7677)
- Recep Bayraktar (ORCID: https://orcid.org/0000-0002-8227-2055)
- Marienid Flores‐Colón
- Patricio Adrián Zapata-Morín (ORCID: https://orcid.org/0000-0003-1851-2293)
- Valeria Villarreal‐García (ORCID: https://orcid.org/0000-0002-4485-4062)
- Cristina Ivan (ORCID: https://orcid.org/0000-0002-4848-0168)
- José Manuel Vázquez-Guillén (ORCID: https://orcid.org/0000-0001-8256-4253)
- Cristina Rodrı́guez-Padilla (ORCID: https://orcid.org/0000-0001-5469-8449)
- Irma Estefanía Ancira-Moreno
Institutions
- The University of Texas MD Anderson Cancer Center (US)
- University of Puerto Rico, Medical Sciences Campus (PR)
- Universidad Autónoma de Nuevo León (MX)
- Al-Azhar University (EG)
Publication Details
- Journal
- Hereditas
- Published
- 2024-12-21
- DOI
- https://doi.org/10.1186/s41065-024-00357-5
- Citations
- 1
- Primary Topic
- MicroRNA in disease regulation
- Type
- article
- Field-Weighted Citation Impact
- 0.29
Funders
- National Institute of General Medical Sciences